KANJI TSUCHIYA

811 total citations
47 papers, 652 citations indexed

About

KANJI TSUCHIYA is a scholar working on Pharmacology, Molecular Medicine and Molecular Biology. According to data from OpenAlex, KANJI TSUCHIYA has authored 47 papers receiving a total of 652 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Pharmacology, 25 papers in Molecular Medicine and 19 papers in Molecular Biology. Recurrent topics in KANJI TSUCHIYA's work include Antibiotic Resistance in Bacteria (25 papers), Antibiotics Pharmacokinetics and Efficacy (22 papers) and Antimicrobial Resistance in Staphylococcus (10 papers). KANJI TSUCHIYA is often cited by papers focused on Antibiotic Resistance in Bacteria (25 papers), Antibiotics Pharmacokinetics and Efficacy (22 papers) and Antimicrobial Resistance in Staphylococcus (10 papers). KANJI TSUCHIYA collaborates with scholars based in Japan and United States. KANJI TSUCHIYA's co-authors include Masahiro Kondo, Takeshi Nishi, T Iwahi, Toshiyuki Yamazaki, Akira Imada, Hiroshi NAGATOMO, Makoto Nakao, Mariko Takeuchi, Yoko Takeuchi and Makoto Kida and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, Infection and Immunity and Journal of Antimicrobial Chemotherapy.

In The Last Decade

KANJI TSUCHIYA

46 papers receiving 520 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
KANJI TSUCHIYA Japan 14 303 219 207 152 95 47 652
Patrick J. Cassidy United States 6 229 0.8× 325 1.5× 312 1.5× 205 1.3× 130 1.4× 8 786
Paul Actor United States 17 320 1.1× 177 0.8× 277 1.3× 167 1.1× 191 2.0× 72 988
P. Acred United Kingdom 14 311 1.0× 236 1.1× 136 0.7× 160 1.1× 62 0.7× 30 675
W. TOSCH Switzerland 10 165 0.5× 237 1.1× 274 1.3× 100 0.7× 74 0.8× 17 669
Barbara A. Pelak United States 14 302 1.0× 241 1.1× 329 1.6× 180 1.2× 175 1.8× 28 939
L. Tybring Denmark 12 392 1.3× 238 1.1× 264 1.3× 167 1.1× 142 1.5× 24 917
G. Beskid United States 16 219 0.7× 184 0.8× 186 0.9× 111 0.7× 93 1.0× 35 531
J. F. Desnottes France 14 186 0.6× 153 0.7× 186 0.9× 144 0.9× 36 0.4× 27 572
L. D. Sabath United States 12 243 0.8× 351 1.6× 232 1.1× 97 0.6× 37 0.4× 13 620
Nigel A. C. Curtis United Kingdom 16 336 1.1× 527 2.4× 392 1.9× 110 0.7× 56 0.6× 25 946

Countries citing papers authored by KANJI TSUCHIYA

Since Specialization
Citations

This map shows the geographic impact of KANJI TSUCHIYA's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by KANJI TSUCHIYA with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites KANJI TSUCHIYA more than expected).

Fields of papers citing papers by KANJI TSUCHIYA

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by KANJI TSUCHIYA. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by KANJI TSUCHIYA. The network helps show where KANJI TSUCHIYA may publish in the future.

Co-authorship network of co-authors of KANJI TSUCHIYA

This figure shows the co-authorship network connecting the top 25 collaborators of KANJI TSUCHIYA. A scholar is included among the top collaborators of KANJI TSUCHIYA based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with KANJI TSUCHIYA. KANJI TSUCHIYA is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
TSUCHIYA, KANJI, et al.. (1991). Application of mathematical model to multiple-dose experimental chemotherapy for fatal murine pneumonia. Antimicrobial Agents and Chemotherapy. 35(6). 1066–1069. 2 indexed citations
2.
TSUCHIYA, KANJI, et al.. (1990). Application of mathematical model to experimental chemotherapy of fatal murine pneumonia. Antimicrobial Agents and Chemotherapy. 34(2). 326–331. 6 indexed citations
3.
4.
Iwahi, T, et al.. (1983). Role of type 1 fimbriae in the pathogenesis of ascending urinary tract infection induced by escherichia coli in mice. Infection and Immunity. 39(3). 1307–1315. 86 indexed citations
5.
Iwahi, T, et al.. (1982). Virulence of Escherichia Coli in Ascending Urinary-tract Infection in Mice. Journal of Medical Microbiology. 15(3). 303–316. 13 indexed citations
6.
Shiho, Osamu & KANJI TSUCHIYA. (1981). IgE antibodies for penicillins and Cephalosporins in rats. III. Antigenic specificity of rat anti-cephalosporin-OvA IgE sera.. The Journal of Antibiotics. 34(1). 84–89. 1 indexed citations
7.
TSUCHIYA, KANJI, Masahiro Kondo, Makoto Kida, et al.. (1981). Cefmenoxime (SCE-1365), a novel broad-spectrum cephalosporin: in vitro and in vivo antibacterial activities. Antimicrobial Agents and Chemotherapy. 19(1). 56–65. 50 indexed citations
8.
Nishi, Takeshi & KANJI TSUCHIYA. (1980). Experimental respiratory tract infection with Klebsiella pneumoniae DT-S in mice: chemotherapy with kanamycin. Antimicrobial Agents and Chemotherapy. 17(3). 494–505. 31 indexed citations
9.
TSUCHIYA, KANJI, et al.. (1978). Absorption, distribution and excretion of cefsulodin, an antipseudomonal cephalosporin, in mice, rats and dogs.. The Journal of Antibiotics. 31(6). 593–597. 2 indexed citations
10.
Nishi, Takeshi & KANJI TSUCHIYA. (1978). Experimental urinary tract infection with Pseudomonas aeruginosa in mice. Infection and Immunity. 22(2). 508–515. 31 indexed citations
11.
Kondo, Masahiro & KANJI TSUCHIYA. (1978). Comparative In Vivo Activities of Cefsulodin, Sulbenicillin, and Gentamicin Against Pseudomonas aeruginosa. Antimicrobial Agents and Chemotherapy. 14(1). 151–153. 9 indexed citations
12.
Yamazaki, Toshiyuki, et al.. (1976). Distribution and Excretion of Sulbenicillin Administered Intravenously to Beagle Dogs. 35(3). 211–216. 2 indexed citations
13.
NAGATOMO, Hiroshi, et al.. (1974). COMBINED ACTION OF SULBENICILLIN AND GENTAMICIN. The Journal of Antibiotics. 27(3). 199–205. 4 indexed citations
14.
Kondo, Masahiro, et al.. (1973). Maridomycin, a New Macrolide Antibiotic: In Vivo Antibacterial Activity of 9-Propionylmaridomycin. Antimicrobial Agents and Chemotherapy. 4(2). 156–159. 1 indexed citations
15.
TSUCHIYA, KANJI, et al.. (1973). IMMUNOLOGICAL CROSS-REACTIONS OF SULFOBENZYLPENICILLIN. The Journal of Antibiotics. 26(9). 485–491. 4 indexed citations
16.
TSUCHIYA, KANJI, et al.. (1972). ABSORPTION, EXCRETION AND TISSUE DISTRIBUTION OF SULFOCILLIN ADMINISTERED PARENTERALLY IN MICE, RATS, RABBITS AND DOGS. The Journal of Antibiotics. 25(6). 336–342. 5 indexed citations
17.
TSUCHIYA, KANJI, et al.. (1971). IN VITRO ANTIBACTERIAL ACTIVITY OF DISODIUM α-SULFOBENZYLPENICILLIN. The Journal of Antibiotics. 24(9). 607–619. 15 indexed citations
18.
TSUCHIYA, KANJI, et al.. (1968). ENDURACIDIN, A NEW ANTIBIOTIC. III. The Journal of Antibiotics. 21(2). 147–153. 14 indexed citations
19.
TSUCHIYA, KANJI & Yoko Takeuchi. (1968). ENDURACIDIN, AN INHIBITOR OF CELL WALL SYNTHESIS. The Journal of Antibiotics. 21(6). 426–428. 14 indexed citations
20.
Kondo, Masahiro & KANJI TSUCHIYA. (1966). The Influence of 5-n-Buthyl-1-Cyclohexyl-2, 4, 6-Trioxoperhydropyrimidine (BCP) on Antibody Formation. Nippon Saikingaku Zasshi. 21(10). 629–632. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Patrick J. Cassidy Breakdown of academic impact, for papers by Paul Actor Breakdown of academic impact, for papers by P. Acred Breakdown of academic impact, for papers by W. TOSCH Breakdown of academic impact, for papers by Barbara A. Pelak Breakdown of academic impact, for papers by L. Tybring Breakdown of academic impact, for papers by G. Beskid Breakdown of academic impact, for papers by J. F. Desnottes Breakdown of academic impact, for papers by L. D. Sabath Breakdown of academic impact, for papers by Nigel A. C. Curtis
Rankless by CCL
2026